Latest & greatest articles for calcium

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on calcium or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on calcium and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for calcium

221. Review: calcium supplementation, with or without vitamin D, prevents osteoporotic fractures in older people

Review: calcium supplementation, with or without vitamin D, prevents osteoporotic fractures in older people Review: calcium supplementation, with or without vitamin D, prevents osteoporotic fractures in older people | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: calcium supplementation, with or without vitamin D, prevents osteoporotic fractures in older people Article Text Therapeutics Review: calcium supplementation, with or without vitamin D, prevents osteoporotic fractures in older people Statistics from Altmetric.com No Altmetric data available

Evidence-Based Medicine (Requires free registration)2008

222. Calcium, dairy foods, and risk of incident and fatal prostate cancer: the NIH-AARP Diet and Health Study

Calcium, dairy foods, and risk of incident and fatal prostate cancer: the NIH-AARP Diet and Health Study 18000020 2007 11 16 2007 12 13 2015 11 19 1476-6256 166 11 2007 Dec 01 American journal of epidemiology Am. J. Epidemiol. Calcium, dairy foods, and risk of incident and fatal prostate cancer: the NIH-AARP Diet and Health Study. 1270-9 Calcium and dairy foods in relation to prostate cancer were examined in the National Institutes of Health (NIH)-AARP (formerly known as the American (...) Association of Retired Persons) Diet and Health Study (1995/1996-2001). Diet was assessed with a food frequency questionnaire at baseline. Multivariate relative risks and 95% confidence intervals were estimated by Cox regression. During up to 6 years of follow-up (n = 293,888), the authors identified 10,180 total prostate cancer cases (8,754 nonadvanced, 1,426 advanced, and 178 fatal cases). Total and supplemental calcium were unrelated to total and nonadvanced prostate cancer. However, a statistically

EvidenceUpdates2008

223. Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease.

Antiproteinuric effect of the calcium channel blocker cilnidipine added to renin-angiotensin inhibition in hypertensive patients with chronic renal disease. Cilnidipine, a dual L-/N-type calcium channel blocker, dilates both efferent and afferent arterioles and is renoprotective. Our multi-center, open-labeled, and randomized trial compared the antiproteinuric effect of cilnidipine with that of amlodipine in hypertensive patients with kidney disease. A group of 339 patients, already receiving

EvidenceUpdates2008

224. Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial.

Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. 18198394 2008 02 04 2008 03 04 2014 09 04 1756-1833 336 7638 2008 Feb 02 BMJ (Clinical research ed.) BMJ Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. 262-6 10.1136/bmj.39440.525752.BE To determine the effect of calcium supplementation on myocardial infarction, stroke, and sudden death in healthy postmenopausal women. Randomised, placebo (...) controlled trial. Academic medical centre in an urban setting in New Zealand. 1471 postmenopausal women (mean age 74): 732 were randomised to calcium supplementation and 739 to placebo. Adverse cardiovascular events over five years: death, sudden death, myocardial infarction, angina, other chest pain, stroke, transient ischaemic attack, and a composite end point of myocardial infarction, stroke, or sudden death. Myocardial infarction was more commonly reported in the calcium group than in the placebo

BMJ2008 Full Text: Link to full Text with Trip Pro

225. Calcium antagonists for aneurysmal subarachnoid haemorrhage.

Calcium antagonists for aneurysmal subarachnoid haemorrhage. BACKGROUND: Secondary ischaemia is a frequent cause of poor outcome in patients with subarachnoid haemorrhage (SAH). Its pathogenesis has been incompletely elucidated, but vasospasm probably is a contributing factor. Experimental studies have suggested that calcium antagonists can prevent or reverse vasospasm and have neuroprotective properties. OBJECTIVES: To determine whether calcium antagonists improve outcome in patients (...) with aneurysmal SAH. SEARCH STRATEGY: We searched the Cochrane Stroke Group Trials Register (last searched April 2006), MEDLINE (1966 to March 2006) and EMBASE (1980 to March 2006). We handsearched two Russian journals (1990 to 2003), and contacted trialists and pharmaceutical companies in 1995 and 1996. SELECTION CRITERIA: Randomised controlled trials comparing calcium antagonists with control, or a second calcium antagonist (magnesium sulphate) versus control in addition to another calcium

Cochrane2007

226. WITHDRAWN: Calcium supplementation on bone loss in postmenopausal women.

WITHDRAWN: Calcium supplementation on bone loss in postmenopausal women. BACKGROUND: Although calcium is one the simplest and least expensive strategies for preventing osteoporotic fractures calcium supplementation is nevertheless not without controversy (Kanis 1989; Nordin 1990). The Food and Drug Administration in the US has permitted a bone health claim for calcium-rich foods, and the NIH in its Consensus Development Process approved a statement that high calcium intake reduces the risk (...) of osteoporosis. OBJECTIVES: To assess the effects of calcium on bone density and fractures in postmenopausal women. SEARCH STRATEGY: We searched Cochrane Controlled Register, MEDLINE and EMBASE up to 2001, and examined citations of relevant articles and proceedings of international meetings. SELECTION CRITERIA: Trials that randomized postmenopausal women to calcium supplementation or usual calcium intake in the diet and reported bone mineral density of the total body, vertebral spine, hip, or forearm

Cochrane2007

227. Review: vitamin D plus calcium, but not vitamin D alone, prevents osteoporotic fractures in older people

Review: vitamin D plus calcium, but not vitamin D alone, prevents osteoporotic fractures in older people Review: vitamin D plus calcium, but not vitamin D alone, prevents osteoporotic fractures in older people | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: vitamin D plus calcium, but not vitamin D alone, prevents osteoporotic fractures in older people Article Text Therapeutics Review: vitamin D plus calcium, but not vitamin D alone, prevents osteoporotic fractures in older people Statistics from Altmetric.com No Altmetric data available

Evidence-Based Medicine (Requires free registration)2007

228. Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials

Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials Bischoff-Ferrari H A, Dawson-Hughes B, Baron J A, Burckhardt P, Li R, Spiegelman D, Specker B (...) , Orav J E, Wong J B, Staehelin H B, O'Reilly E, Kiel D P, Willett W C CRD summary The authors concluded that calcium intake was associated with a reduced hip fracture risk in neither men nor women. This was a generally well-conducted review, but in light of the uncertain quality of included studies the reliability of the conclusions was unclear. Authors' objectives To assess the relationship between calcium intake and the risk of hip fracture. Searching MEDLINE (January 1960 to December 2006

DARE.2007

229. The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker

The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker The development of new-onset type 2 diabetes associated with choosing a calcium channel blocker compared to a diuretic or beta-blocker Kuti E L, Baker W L, White C M CRD summary This review concluded that calcium-channel blockers (...) for the treatment of hypertension appear to reduce the risk of developing new-onset type two diabetes mellitus compared with treatment with β-blockers and/or diuretics. However, given the differences between the studies and several potential limitations of the review methodology, the reliability of the authors' conclusions is unclear. Authors' objectives To examine the effects of calcium-channel blockers (CCBs), compared with β-blockers and diuretics, on new-onset type two diabetes mellitus in patients

DARE.2007

230. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis

Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis Tang B M, Eslick G D (...) , Nowson C, Smith C, Bensoussan A CRD summary The authors' conclusion that the evidence supports the use of calcium, or calcium in combination with vitamin D supplementation, for osteoporotic fractures and bone mineral density in adults over 50 appears to follow from the results presented. The authors' conclusions are likely to be reliable. Authors' objectives To determine the efficacy of calcium supplementation, with or without vitamin D, for the prevention of osteoporotic fractures and bone loss

DARE.2007

231. Effect of maternal calcium intake during pregnancy on children's blood pressure: a systematic review of the literature

Effect of maternal calcium intake during pregnancy on children's blood pressure: a systematic review of the literature Effect of maternal calcium intake during pregnancy on children's blood pressure: a systematic review of the literature Effect of maternal calcium intake during pregnancy on children's blood pressure: a systematic review of the literature Bergel E, Barros A J CRD summary This review summarised published evidence on the association between maternal dietary calcium intake during (...) pregnancy and blood-pressure in the offspring. The authors concluded that there is evidence to support such an association, but more research is needed to confirm it. Despite the potential for bias in the review methods, these cautious conclusions appear reasonably reliable on the basis of the presented evidence. Authors' objectives To summarise the evidence on the association between maternal dietary calcium intake during pregnancy and blood-pressure (BP) in the offspring. Searching MEDLINE, EMBASE

DARE.2007

232. Cost effectiveness of coronary angiography and calcium scoring using CT and stress MRI for diagnosis of coronary artery disease

Cost effectiveness of coronary angiography and calcium scoring using CT and stress MRI for diagnosis of coronary artery disease Cost effectiveness of coronary angiography and calcium scoring using CT and stress MRI for diagnosis of coronary artery disease Cost effectiveness of coronary angiography and calcium scoring using CT and stress MRI for diagnosis of coronary artery disease Dewey M, Hamm B Record Status This is a critical abstract of an economic evaluation that meets the criteria (...) for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn. Health technology The study examined six strategies for the diagnosis of coronary artery disease (CAD). In particular, three new strategies were compared with three conventional approaches. The new options were coronary angiography using multislice computed tomography (MSCT), calcium scoring using

NHS Economic Evaluation Database.2007

233. Should patients receiving a radial artery conduit have post-operative Calcium Channel blockers ?

Should patients receiving a radial artery conduit have post-operative Calcium Channel blockers ? BestBets: Should patients receiving a radial artery conduit have post-operative Calcium Channel blockers ? Should patients receiving a radial artery conduit have post-operative Calcium Channel blockers ? Report By: Anish Patel, Sanjay Asopa - Specialist Registrars in Cardiothoracic Surgery Search checked by Joel Dunning - Specialist Registrar RCS Institution: Wessex Cardiothoracic Unit Date (...) was on no medication on admission and asks you why he needs to have 6 weeks of Diltiazem three times per day as prescribed by your consultant. You have some difficulty justifying this medication and thus resolve to look up the literature that night. Search Strategy Medline1966 to Jan 2006. [Exp coronary artery bypass/OR coronary bypass.mp/OR coronary art$ bypass.mp OR CABG.mp OR exp Thoracic surgery/]AND[exp Radial artery/ OR radial arter$.mp]AND[exp calcium channel blockers/OR calcium channel blocker$.mp

BestBETS2007

234. Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults.

Combined calcium, magnesium and potassium supplementation for the management of primary hypertension in adults. BACKGROUND: Previous research suggests that increasing dietary intakes of calcium, potassium or magnesium separately may reduce BP to a small degree over the short term. It is unclear whether increasing intakes of a combination of these minerals produces a larger reduction in BP. OBJECTIVES: To evaluate the effects of combined mineral supplementation as a treatment for primary (...) a combination of potassium, and/or calcium, and/or magnesium with placebo, no treatment, or usual care; 2) treatment and follow-up >=8 weeks; 3) participants over 18 years old, with raised systolic blood pressure (SBP) >=140 mmHg or diastolic blood pressure (DBP) >=85 mmHg with no known primary cause; 4) SBP and DBP reported at end of follow-up. We excluded trials where participants were pregnant, or received antihypertensive medication which changed during the study. DATA COLLECTION AND ANALYSIS

Cochrane2006

235. Psychosocial factors and coronary calcium in adults without clinical cardiovascular disease.

Psychosocial factors and coronary calcium in adults without clinical cardiovascular disease. BACKGROUND: Psychosocial factors have been linked to coronary events, but the mechanisms underlying these associations have not been established. Evidence is mixed regarding associations of psychosocial factors with subclinical coronary atherosclerosis. OBJECTIVE: To examine associations of 4 psychosocial factors (depressive symptoms, anger, anxiety, and chronic stress) with the presence of subclinical (...) coronary atherosclerosis. DESIGN: Cross-sectional study. SETTING: The Multiethnic Study of Atherosclerosis, a population-based study of subclinical atherosclerosis. PATIENTS: A multiethnic sample of 6789 adults, 45 to 84 years of age, with no history of clinical cardiovascular disease. MEASUREMENTS: Coronary calcium was assessed by using chest computed tomography, and psychosocial factors were assessed by using questionnaires with validated scales. RESULTS: There was no evidence that higher levels

Annals of Internal Medicine2006

236. Amlodipine besylate/ atorvastatin calcium

Amlodipine besylate/ atorvastatin calcium Common Drug Review CEDAC Meeting – April 19, 2006 Page 1 of 1 Notice of CEDAC Final Recommendation – May 17, 2006 CEDAC FINAL RECOMMENDATION and REASONS for RECOMMENDATION AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM (Caduet ™ – Pfizer Canada Inc.) Description: Caduet ™ is a fixed dose combination of amlodipine and atorvastatin and is approved for use in patients for whom treatment with both amlodipine and atorvastatin is appropriate, specifically

Canadian Agency for Drugs and Technologies in Health - Common Drug Review2006

237. Education, 15-year risk factor progression, and coronary artery calcium in young adulthood and early middle age: the Coronary Artery Risk Development in Young Adults study.

Education, 15-year risk factor progression, and coronary artery calcium in young adulthood and early middle age: the Coronary Artery Risk Development in Young Adults study. CONTEXT: The inverse association between education and cardiovascular disease is well established, but little is known about the relationship between education and subclinical disease, which is free from medical access and treatment-related influences, or about possible mediating pathways for these relationships. OBJECTIVE (...) : To examine the association of education with coronary artery calcium (CAC), an indicator of subclinical atherosclerosis, and cardiovascular risk factors, and their changes as potential mediators. DESIGN, SETTING, AND PARTICIPANTS: A population-based, prospective, observational study (Coronary Artery Risk Development in Young Adults [CARDIA]) of 2913 eligible participants (44.9% black; 53.9% women) recruited from 4 metropolitan areas (Birmingham, Ala; Chicago, Ill; Minneapolis, Minn; and Oakland, Calif

JAMA2006

238. Etidronate, calcium, or both did not reduce fracture rates in patients with asthma receiving glucocorticoid treatment

Etidronate, calcium, or both did not reduce fracture rates in patients with asthma receiving glucocorticoid treatment Etidronate, calcium, or both did not reduce fracture rates in patients with asthma receiving glucocorticoid treatment | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name (...) or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Etidronate, calcium, or both did not reduce fracture rates in patients with asthma receiving glucocorticoid treatment Article Text Therapeutics Etidronate, calcium, or both did not reduce fracture rates in patients with asthma receiving glucocorticoid treatment Free Sophie

Evidence-Based Medicine (Requires free registration)2006

239. Calcium did not prevent fractures in elderly women

Calcium did not prevent fractures in elderly women Calcium did not prevent fractures in elderly women | Evidence-Based Medicine This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? You are here Calcium did not prevent fractures in elderly women Article Text Therapeutics Calcium did not prevent fractures in elderly women Statistics from Altmetric.com No Altmetric data available for this article. Request permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick

Evidence-Based Medicine (Requires free registration)2006

240. Calcium plus vitamin D did not prevent fractures or colorectal cancer in postmenopausal women

Calcium plus vitamin D did not prevent fractures or colorectal cancer in postmenopausal women Calcium plus vitamin D did not prevent fractures or colorectal cancer in postmenopausal women | Evidence-Based Nursing This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search (...) for this keyword Search for this keyword Main menu Log in via your Society Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Calcium plus vitamin D did not prevent fractures or colorectal cancer in postmenopausal women Article Text Treatment Calcium plus vitamin D did not prevent fractures or colorectal cancer in postmenopausal women Statistics from Altmetric.com No Altmetric data available

Evidence-Based Nursing (Requires free registration)2006